Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$17,512,382
+$2,035,359 QoQ
Shares Held
69,593
-2.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.25%
of 13F equity value
Holder Rank
#668
of 4,152 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BOSTON FAMILY OFFICE LLC holds $74,645,423 across 10 Drug Manufacturers - General names. ABBV ranks #2 (23.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,325 | $21,979,556 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
69,593 | $17,512,382 | |
| 3 | JNJ |
Johnson & Johnson
|
68,219 | $17,325,579 | |
| 4 | MRK |
Merck & Co., Inc.
|
43,081 | $5,535,908 | |
| 5 | AMGN |
Amgen Inc
|
10,368 | $3,754,460 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
16,037 | $2,026,114 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
31,077 | $1,790,656 | |
| 8 | NVO |
Novo Nordisk A S
|
36,941 | $1,770,951 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,512,382 | 69,593 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $15,477,023 | 71,162 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $16,273,743 | 71,223 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $17,387,496 | 75,095 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $13,371,136 | 72,035 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $15,214,504 | 72,616 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $13,062,016 | 73,506 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $14,775,651 | 74,821 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $12,841,016 | 74,866 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $14,085,070 | 77,348 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $12,294,854 | 79,337 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $11,994,560 | 80,468 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $10,854,387 | 80,564 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $13,224,522 | 82,980 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $13,608,370 | 84,205 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $11,310,681 | 84,276 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $13,457,862 | 87,868 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $14,523,434 | 89,590 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $11,684,343 | 86,295 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,540,993 | 88,449 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $9,900,042 | 87,891 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $9,737,527 | 89,979 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $9,688,931 | 90,424 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,383,924 | 84,301 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $7,180,688 | 73,138 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $5,598,898 | 73,486 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||